会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明申请
    • PHARMACEUTICAL DISPENSING APPARATUS
    • 药用配料设备
    • WO2012121663A1
    • 2012-09-13
    • PCT/SG2011/000092
    • 2011-03-09
    • GETECH AUTOMATION PTE LTDBIRCH, Peter, FollettDAMODARAN, SuneailWU, Yan Fang
    • BIRCH, Peter, FollettDAMODARAN, SuneailWU, Yan Fang
    • G07F11/28B65D83/08
    • G07F17/0092G07F11/42
    • A pharmaceutical dispensing apparatus (100) for dispensing pharmaceutical packages containing pharmaceuticals is disclosed herein. In a described embodiment, the apparatus (100) comprises an array of dispensing cartridges (200) adapted to receive a plurality of individual pharmaceutical packages in the form of blister packs (212). Each dispensing cartridge (200) has a longitudinal axis (106) and arranged to support the individual blister pack (212) at a load angle of between 20° and 38°, the load angle being an angle formed between the longitudinal axis (106) and a horizontal axis (108) of the apparatus. The pharmaceutical dispensing apparatus (100) also includes a pick-and-place mechanism (300) operable to selectively remove the blister pack (212) from the array of dispensing cartridges (200).
    • 本文公开了用于分配包含药物的药物包装的药物分配装置(100)。 在所描述的实施例中,设备(100)包括适于接收泡罩包装(212)形式的多个单独药物包装的分配盒(200)阵列。 每个分配盒(200)具有纵向轴线(106)并且布置成以各自的泡罩包装(212)以20°和38°之间的载荷角度支撑,所述负载角度是在所述纵向轴线(106) 和装置的横轴(108)。 药物分配装置(100)还包括拾取和放置机构(300),其可操作以从分配盒(200)的阵列中选择性地移除泡罩包装(212)。
    • 5. 发明申请
    • COMMUNICATION METHOD, SYSTEM AND NETWORK NODES IN A LOW POWER COMMUNICATION NETWORK
    • 低功率通信网络中的通信方法,系统和网络节点
    • WO2009053480A1
    • 2009-04-30
    • PCT/EP2008/064484
    • 2008-10-24
    • SIEMENS AKTIENGESELLSCHAFTLAMPE, MattiasLI, Juan JuanTONG, JieWU, JinYAN, Fang
    • LAMPE, MattiasLI, Juan JuanTONG, JieWU, JinYAN, Fang
    • H04W48/12
    • H04W48/12H04W52/0219H04W84/18Y02D70/142
    • The present invention provides a communication method in a low power communication network, a corresponding low power communication network system and a network node, which enables low power consumption by the data transmission node in the low power communication network while ensuring the communication efficiency of the low power communication network. In this case, the network comprises a first network node and a second network node; the first network node transmits a beacon frame, said beacon frame is used to indicate the time for data transmission by the first network node; the second network node detects said beacon frame to synchronize its data transmission with the first network node. Furthermore, the first network node transmits a dummy beacon frame before it transmits the beacon frame, said dummy beacon frame is used to indicate the time for transmitting the beacon frame; the second network node detects the dummy beacon frame before it detects the beacon frame to acquire the time for transmitting the beacon frame, and carries out data transmission with the first network node synchronously after it has detected the beacon frame.
    • 本发明提供了一种低功率通信网络中的通信方法,相应的低功率通信网络系统和网络节点,其能够实现低功率通信网络中的数据传输节点的低功耗,同时确保低功率通信网络的通信效率 电力通信网络。 在这种情况下,网络包括第一网络节点和第二网络节点; 第一网络节点发送信标帧,所述信标帧用于指示第一网络节点进行数据传输的时间; 第二网络节点检测所述信标帧以使其数据传输与第一网络节点同步。 此外,第一网络节点在发送信标帧之前发送虚拟信标帧,所述虚拟信标帧用于指示发送信标帧的时间; 第二网络节点在检测到信标帧之前检测虚拟信标帧以获取用于发送信标帧的时间,并且在检测到信标帧之后同步地执行与第一网络节点的数据传输。
    • 9. 发明授权
    • Process of constructing oxidation-reduction nanomedicine quantum dots room temperature quantum bit networks
    • US08304758B2
    • 2012-11-06
    • US12002888
    • 2007-12-19
    • Yan Fang
    • Yan Fang
    • H01L31/00
    • A61K41/0004
    • Preparation of oxidation-reduction (redox) nano-medicine quantum dot room temperature superconductor quantum bit (qubit) networks includes processes of making unitary, binary, ternary, an d/or quaternary liquid pharmaceutical ingredients of an antioxidase antioxidant, a β-adrenergic receptor agonist, a P2-purinergic receptor agonist, and/or a phenylalkylamine calcium channel blocker in combination with either 1:20 xanthine oxidase (XO):xanthine (X) or X alone in a liquid phase by using the L16(2)15 and L9(3)4 orthogonal optimization design protocols and modulating spatial distance constraint from about 0.1 Å to about 200 Å as well as a 10 class clean bottom-up self-assembly approach. Redox nano-drug quantum dot superconductor qubit network can be identified at room temperature by Planck constant (ℏ)-related qubit metrology of electron spins and polaritons (the quantum state of photon-exciton hybrid or photoelectron coupling/co-tunneling) through conducting atomic force microscopy (C-AFM) and/or laser micro-photoluminescence (PL) spectrum standard measurement method, wherein ℏ-related quantum continuous variables (QCVs) are derived from faster Fourier transformation (FFT) of average current-voltage (I-V) curves and PL spectra, their first derivatives of relative phases in frequency and time domains (dr/df=ΔE/ℏ and dr/dt=ΔE/ℏ) and their FFTs to acquire Σ(2n), Σ(2n·2n), Σ(2n+1), Σ(2n·2n), Σ(22n+1·22n+1) and/or Σ(22n+1) binary superconductor qubit matrix networks. Uses of this invention cover room temperature superconductor (resistance loss, insulator with conductor or ∞ conductance) quantum devices and quantum biology metrology, implanted nano-drug quantum dot diagnostic and therapeutic nanodevices and/or nano-bio-electrochemistry sensors with target-recognized functions.